Overall, levels in most patients screened with MCP-1, MIP-1α, IL-8, and MCP-3 were above the concentration range of healthy individuals; however, IP-10 and MIG were markedly elevated in most patients upon admission to the ICU and then rapidly declined with the resolution of COVID–19. This evidence concerns the gene CCL2 and COVID-19.